CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
Lung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/1/1713 |
id |
doaj-2ce0475e166a49e6a121ac5937f0f206 |
---|---|
record_format |
Article |
spelling |
doaj-2ce0475e166a49e6a121ac5937f0f2062020-11-24T21:28:34ZengMDPI AGInternational Journal of Molecular Sciences1422-00672013-01-011411713172710.3390/ijms14011713CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the BrainSebastiano CavallaroLung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain. It is critical to understand the biologic basis of brain metastases to develop novel diagnostic and therapeutic approaches. This review will focus on the emerging data supporting the involvement of the chemokine CXCL12 and its receptor CXCR4 in the brain metastatic evolution of non-small-cell lung cancer (NSCLC) and the pharmacological tools that may be used to interfere with this signaling axis.http://www.mdpi.com/1422-0067/14/1/1713brain metastaseschemokinesCXCL12CXCR4lung cancermetastasis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sebastiano Cavallaro |
spellingShingle |
Sebastiano Cavallaro CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain International Journal of Molecular Sciences brain metastases chemokines CXCL12 CXCR4 lung cancer metastasis |
author_facet |
Sebastiano Cavallaro |
author_sort |
Sebastiano Cavallaro |
title |
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain |
title_short |
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain |
title_full |
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain |
title_fullStr |
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain |
title_full_unstemmed |
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain |
title_sort |
cxcr4/cxcl12 in non-small-cell lung cancer metastasis to the brain |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2013-01-01 |
description |
Lung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain. It is critical to understand the biologic basis of brain metastases to develop novel diagnostic and therapeutic approaches. This review will focus on the emerging data supporting the involvement of the chemokine CXCL12 and its receptor CXCR4 in the brain metastatic evolution of non-small-cell lung cancer (NSCLC) and the pharmacological tools that may be used to interfere with this signaling axis. |
topic |
brain metastases chemokines CXCL12 CXCR4 lung cancer metastasis |
url |
http://www.mdpi.com/1422-0067/14/1/1713 |
work_keys_str_mv |
AT sebastianocavallaro cxcr4cxcl12innonsmallcelllungcancermetastasistothebrain |
_version_ |
1725969714623021056 |